Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota
{{output}}
Compositional changes in the microbiota (dysbiosis) may be a basis for Irritable Bowel Syndrome (IBS), but biomarkers are currently unavailable to direct microbiota-directed therapy. We therefore examined whether changes in fecal β-defensin could be a marker ... ...
